Molecular mechanisms mediating the beneficial metabolic effects of [Arg⁴]tigerinin-1R in mice with diet-induced obesity and insulin resistance

References

Abdel-Wahab, Y.H.A., Power, G.J., Ng, T.M., Flatt, P.R., and Conlon, J.M. (2008). Insulin-releasing properties of the frog skin peptide pseudin-2 and its [Lys18]-substituted analogue. Biol. Chem. 389, 143–148.10.1515/BC.2008.018Search in Google Scholar

Andrali, S.S., Sampley, M.L., Vanderford, N.L., and Ozcan, S. (2008). Glucose regulation of insulin gene expression in pancreatic beta-cells. Biochem. J. 415, 1–10.10.1042/BJ20081029Search in Google Scholar

Bustillo, M.E., Fischer, A.L., LaBouyer, M.A., Klaips, J.A., Webb, A.C., and Elmore, D.E. (2014). Modular analysis of hipposin, a histone-derived antimicrobial peptide consisting of membrane translocating and membrane permeabilizing fragments. Biochim. Biophys. Acta 1838, 2228–2233.10.1016/j.bbamem.2014.04.010Search in Google Scholar

Chan, S.M. and Ye, J.M. (2013). Strategies for the discovery and development of anti-diabetic drugs from the natural products of traditional medicines. J. Pharm. Pharm. Sci. 16, 207–216.10.18433/J3T60GSearch in Google Scholar

Conlon, J.M., Mechkarska, M., Lukic, M.L., and Flatt, P.R. (2014). Potential therapeutic applications of multifunctional host-defense peptides from frog skin as anti-cancer, anti-viral, immunomodulatory, and anti-diabetic agents. Peptides 57, 67–77.10.1016/j.peptides.2014.04.019Search in Google Scholar

Consoli, A. and Formoso, G. (2015). Potential side effects to GLP-1 agonists: understanding their safety and tolerability. Expert Opin. Drug Saf. 14, 207–218.10.1517/14740338.2015.987122Search in Google Scholar

D’Alessio, D. (2011). The role of dysregulated glucagon secretion in type 2 diabetes. Diabetes Obes. Metab. 13, 126–132.10.1111/j.1463-1326.2011.01449.xSearch in Google Scholar

De Marinis, Y.Z., Salehi, A., Ward, C.E., Zhang, Q., Abdulkader, F., Bengtsson, M., Braha, O., Braun, M., Ramracheya, R., Amisten, S., et al. (2010). GLP-1 inhibits and adrenaline stimulates glucagon release by differential modulation of N- and L-type Ca2+ channel-dependent exocytosis. Cell Metab. 11, 543–553.10.1016/j.cmet.2010.04.007Search in Google Scholar

Eng, J., Kleinman, W.A., Singh, L., Singh, G., and Raufman. J.P. (1992). Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom. J. Biol. Chem. 267, 7402–7405.10.1016/S0021-9258(18)42531-8Search in Google Scholar

Flatt, P.R. and Bailey, C.J. (1981). Abnormal plasma glucose and insulin responses in heterozygous lean (ob/+) mice. Diabetologia 20, 573–577.10.1007/BF00252768Search in Google Scholar PubMed

Gao, M., Ma, Y., and Liu, D. (2015). High-fat diet-induced adiposity, adipose inflammation, hepatic steatosis and hyperinsulinemia in outbred CD-1 mice. PLoS One 10, e0119784.10.1371/journal.pone.0119784Search in Google Scholar

Ginn, C., Khalili, H., Lever, R., and Brocchini, S. (2014). PEGylation and its impact on the design of new protein-based medicines. Future Med. Chem. 6, 1829–1846.10.4155/fmc.14.125Search in Google Scholar

Kahn, S., Cooper, M.E., and Del Prato, S. (2014). Pathophysiology and treatment of type 2 diabetes: perspective on the past, present and future. Lancet 383, 1068–1083.10.1016/S0140-6736(13)62154-6Search in Google Scholar

Lee, H.S., Park, C.B., Kim, J.M., Jang, S.A., Park, I.Y., Kim, M.S., Cho, J.H., and Kim, S.C. (2008). Mechanism of anticancer activity of buforin IIb, a histone H2A-derived peptide. Cancer Lett. 271, 47–55.10.1016/j.canlet.2008.05.041Search in Google Scholar PubMed

Moran, B.M., Abdel-Wahab, Y.H., Flatt, P.R., and McKillop, A.M. (2014). Activation of GPR119 by fatty acid agonists augments insulin release from clonal B-cells and isolated pancreatic islets and improves glucose tolerance in mice. Biol. Chem. 395, 453–464.10.1515/hsz-2013-0255Search in Google Scholar PubMed

Ojo, O.O., Abdel-Wahab, Y.H.A., Flatt, P.R., Mechkarska, M., and Conlon, J.M. (2011). Tigerinin-1R: a potent, non-toxic insulin-releasing peptide isolated from the skin of the Asian frog, Hoplobatrachus rugulosus. Diabetes Obes. Metab. 13, 1114–1122.10.1111/j.1463-1326.2011.01470.xSearch in Google Scholar PubMed

Ojo, O.O., Abdel-Wahab, Y.H., Flatt, P.R., and Conlon, J.M. (2013). Insulinotropic actions of the frog skin host-defense peptide alyteserin-2a: a structure-activity study. Chem. Biol. Drug Des. 82, 196–204.10.1111/cbdd.12151Search in Google Scholar PubMed

Ojo, O.O., Srinivasan, D.K., Owolabi, B.O., Flatt, P.R., and Abdel-Wahab, Y.H.A. (2015a). Beneficial effects of tigerinin-1R on glucose homeostasis and beta cell function in mice with diet-induced obesity-diabetes. Biochimie 109, 18–26.10.1016/j.biochi.2014.11.018Search in Google Scholar PubMed

Ojo, O.O., Srinivasan, D.K., Owolabi, B.O., Conlon, J.M., Flatt, P.R., Abdel-Wahab, Y.H.A. (2015b). Magainin-AM2 improves glucose homeostasis and beta cell function in high-fat fed mice. Biochim. Biophys. Acta 1850, 80–87.10.1016/j.bbagen.2014.10.011Search in Google Scholar PubMed

Østergaard, L., Frandsen, C.S., and Madsbad, S. (2016) Treatment potential of the GLP-1 receptor agonists in type 2 diabetes mellitus: a review. Expert Rev. Clin. Pharmacol. 8, 1–25.10.1586/17512433.2016.1121808Search in Google Scholar PubMed

Owolabi, B.O., Ojo, O.O., Srinivasan, D.K., Conlon, J.M., Flatt, P.R., and Abdel-Wahab, Y.H. (2016). In vitro and in vivo insulinotropic properties of the multifunctional frog skin peptide hymenochirin-1B: a structure-activity study. Amino Acids 48, 535–547.10.1007/s00726-015-2107-xSearch in Google Scholar PubMed

Pantic, J.M., Mechkarska, M., Lukic, M.L., and Conlon, J.M. (2014) Effects of tigerinin peptides on cytokine production by mouse peritoneal macrophages and spleen cells and by human peripheral blood mononuclear cells. Biochimie 101, 83–92.10.1016/j.biochi.2013.12.022Search in Google Scholar PubMed

Pukala, T.L., Bowie, J.H., Maselli, V.M., Musgrave, I.F., and Tyler, M.J. (2006). Host-defence peptides from the glandular secretions of amphibians: structure and activity. Nat. Prod. Rep. 23, 368–393.10.1039/b512118nSearch in Google Scholar PubMed

Richter, E.A. and Hargreaves, M. (2013). Exercise, GLUT4, and skeletal muscle glucose uptake. Physiol. Rev. 93, 993–1017.10.1152/physrev.00038.2012Search in Google Scholar PubMed

Saini, V. (2010). Molecular mechanisms of insulin resistance in type 2 diabetes mellitus. World J. Diabetes 1, 68–75.10.4239/wjd.v1.i3.68Search in Google Scholar PubMed PubMed Central

Samuel, V.T. and Shulman, G.I. (2012). Mechanisms for insulin resistance: common threads and missing links. Cell 148, 852–871.10.1016/j.cell.2012.02.017Search in Google Scholar PubMed PubMed Central

Scholfield, C.N. and Curtis, T.M. (2000). Heterogeneity in cytosolic calcium regulation among different microvascular smooth muscle cells of the rat retina. Microvasc. Res. 59, 233–242.10.1006/mvre.1999.2227Search in Google Scholar PubMed

Srinivasan, D., Ojo, O.O., Abdel-Wahab, Y.H.A., Flatt, P.R., Guilhaudis, L., and Conlon, J.M. (2014). Insulin-releasing and cytotoxic properties of the frog skin peptide, tigerinin-1R: A structure-activity study. Peptides 55, 23–31.10.1016/j.peptides.2014.02.002Search in Google Scholar PubMed

Srinivasan, D.K., Ojo, O.O., Owolabi, B.O., Conlon, J.M., Flatt, P.R., and Abdel-Wahab, Y.H.A. (2015). The frog skin host-defense peptide CPF-SE1 improves glucose tolerance, insulin sensitivity and islet function and decreases plasma lipids in high-fat fed mice. Eur. J. Pharmacol. 5, 38–47.10.1016/j.ejphar.2015.06.042Search in Google Scholar PubMed

Srinivasan, D.K., Ojo, O.O., Owolabi, B.O., Conlon, J.M., Flatt, P.R., and Abdel-Wahab, Y.H.A. (2016). [I10W]tigerinin-1R enhances both insulin sensitivity and pancreatic beta cell function and decreases adiposity and plasma triglycerides in high-fat mice. Acta Diabetol. in press.10.1007/s00592-015-0783-3Search in Google Scholar PubMed

Syed, Y.Y. and McCormack, P.L. (2015). Exenatide extended-release: An updated review of its use in Type 2 Diabetes Mellitus. Drugs 75, 1141–1152.10.1007/s40265-015-0420-zSearch in Google Scholar

Wald, N.J., Bestwick, J.P., and Morris, J.K. (2012). Body weight reduction to avoid the excess risk of type 2 diabetes. Br. J. Gen. Pract. 62, e411–e414.10.3399/bjgp12X649098Search in Google Scholar

White, M.F., Shoelson, S.E., Keutmann H., and Kahn, C.R., 1988. A cascade of tyrosine autophosphorylation in the beta-subunit activates the phosphotransferase of the insulin receptor. J. Biol. Chem. 263, 2969–2980.10.1016/S0021-9258(18)69163-XSearch in Google Scholar

Wilcox, G. (2005). Insulin and insulin resistance. Clin. Biochem. Rev. 26, 19–36.Search in Google Scholar

Winzell, M.S.and Ahren, B. (2004). The high-fat diet-fed mouse: A model for studying mechanisms and treatment of impaired glucose tolerance and type 2 diabetes. Diabetes 53, S215–S219.10.2337/diabetes.53.suppl_3.S215Search in Google Scholar PubMed

Xu, X. and Lai, R. (2015). The chemistry and biological activities of peptides from amphibian skin secretions. Chem. Rev. 115, 1760–1846.10.1021/cr4006704Search in Google Scholar PubMed